MENLO PARK, Calif. – LevitasBio has announced the expansion of its product portfolio with the release of two new product lines that will enable researchers and laboratory personnel to better process and characterize human, animal and plant samples. As is widely understood, optimal cellular-based research results will typically depend upon the purity and viability of […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and ARUP Laboratories announced today they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased. ARUP Laboratories has purchased a PacBio Sequel IIe system for use in the Utah NeoSeq Project. The project, […]
Company broadens range of workflows in “Functional Cell Library” to accelerate cell therapy manufacturing and clinical studies BRANFORD, Conn. — IsoPlexis Corporation (NASDAQ: ISO), the leader in functional single-cell proteomics, today announced the publication of two high-impact clinical research studies in Nature Medicine. Both papers demonstrate the unique utility of IsoPlexis’ single-cell proteomic platform for predicting the potency […]
SOUTH SAN FRANCISCO, Calif. & BOSTON — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Invetx, a pioneer in protein-based therapeutics for animal health, today announced an extension to their existing antibody therapeutic partnership. The extended agreement covers the addition […]
Ulm, Germany — The life science group Sartorius officially opened its Cell Culture Technology Center at Science Park III, a major hub for cutting–edge research and scientific discovery near many of Germany’s top universities. Around 120 employees work at this Sartorius facility featuring special laboratories and covering 6,000 square meters, some 65,000 square feet, to develop cell lines […]
ST. LOUIS, Mo. — Leinco Technologies, a specialty manufacturer of life science reagents used in drug discovery research and in vitro diagnostics applications, today announced a majority recapitalization of the company by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to […]
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), and Sequoia Capital China, a leading investment firm, today jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. Located in Zhangjiang […]
Seasoned finance and life sciences executive, Brandon Poe, joins rapidly growing team, supporting company growth SAN DIEGO, CA – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today that Brandon Poe has joined as Chief Financial Officer. Poe brings 25 years of financial experience in the life sciences, […]
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), world-renowned for its groundbreaking research, announced they have entered into […]
Single-cell spatial genomics instrument pioneer appoints genomics commercialization expert CAMBRIDGE, Mass. – Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announces the appointment of Matt Posard to their Board of Directors. As the first outside director for Vizgen, Matt will provide guidance to expand market strategies […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
